MedTrace Logo

Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients

NCT00348634 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-03-04

No results posted yet for this study

Summary

This study will evaluate the effects of tegaserod on orocecal and colonic transit in patients over 65 years with chronic constipation.

Conditions

  • Chronic Constipation

Interventions

DRUG

Tegaserod

Sponsors & Collaborators

Principal Investigators

  • Henry Parkman, MD · Temple

  • William Chey, MD · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2007-04-30
Completion
2007-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00348634 on ClinicalTrials.gov